Champlin, MN, United States of America

Jeffrey Allen McBroom

This inventor holds 11 USPTO granted patents and 4 published patent applications. Top assignees: Cardiovascular Systems, Inc., Spectra Science Corporation, Medamicus, Inc.. Active years: 1995-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Allen McBroom. Retrieved from https://idiyas.com/inventor/jeffrey-allen-mcbroom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 90.9

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 1,457(Granted Patents)


Company Filing History:


Years Active: 1995-2022

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Jeffrey Allen McBroom

Introduction:

Jeffrey Allen McBroom, hailing from Champlin, MN (US), is a distinguished inventor who has left an indelible mark in the realm of intraluminal drug delivery systems. With an impressive portfolio of 11 patents under his belt, McBroom is recognized for his groundbreaking work in enhancing drug delivery and uptake mechanisms in biological conduits.

Latest Patents:

McBroom's latest patents showcase his pioneering spirit in developing devices, systems, and methods for optimizing intraluminal drug delivery and uptake. His innovations revolve around the utilization of ultrasound energy in conjunction with microbubbles to enhance the absorption of therapeutic agents in vascular lumens. Additionally, McBroom's inventions include the application of drugs in a cyclic manner using a pulse generator synced with a patient's blood pulsing frequency.

Career Highlights:

Having contributed significantly to the field of medical technology, Jeffrey Allen McBroom has lent his expertise to reputable companies such as Cardiovascular Systems, Inc., and Spectra Science Corporation. His unwavering dedication to advancing drug delivery technologies has garnered him acclaim within the industry.

Collaborations:

Throughout his career, McBroom has collaborated with esteemed professionals in the field, including Richard Charles Gunderson and James S Sharrow. Together, they have synergized their expertise to drive innovation and develop cutting-edge solutions for intraluminal drug delivery.

Conclusion:

In conclusion, Jeffrey Allen McBroom stands as a beacon of innovation in the realm of medical technology, with a proven track record of revolutionizing drug delivery systems. His relentless pursuit of excellence and collaborative efforts underscore his commitment to advancing healthcare solutions, thereby leaving a lasting impact on the industry and the lives of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…